Numerous studies have shown that OPN expression was increased in the kidneys, blood and urine of patients with CKD (diabetic nephropathy, glomerulonephritis and immunoglobulin A nephropathy), suggesting that OPN might be a biomarker for CKD [35, 36]. This evidence concerns the gene SPP1 and glomerulonephritis.